首页 > 最新文献

Pakistan Journal of Medical & Health Sciences最新文献

英文 中文
Association of Access to the Radial Artery with Reduced Incidence of Acute Kidney Injury 桡动脉通路与降低急性肾损伤发生率的关系
Q4 Medicine Pub Date : 2023-10-31 DOI: 10.54393/pjhs.v4i10.1100
Sanjay Gandhi, Haris Khan, Umer Bin Tariq, Gulfan Ullah, Akmal Zubair
The research looks at access to the radial artery in contemporary medicine to lower the occurrence of acute kidney injury (AKI). In an effort to increase patient-centered procedural safety, it evaluates evidence contrasting radial versus femoral access. Objective: To determine if access to the radial artery and the prevalence of AKI during interventional procedures, with an emphasis on evaluating the possible advantages of radial access in lowering the risk of AKI. Methods: An examination of 132 instances classified by access location (radial artery as opposed to other sites) was done retrospectively. Beginning in September 2022 and ending in March 2023, the study's length was six months. AKI incidence, procedure specifics, and demographic data were compared. The independent influence of radial access on the risk of AKI was evaluated using multivariate logistic regression. Results: The radial artery group (13.6%) exhibited a significantly lower AKI incidence than the comparator group (27.3%). Multivariate analysis confirmed the independent association. Conclusions: The possible relevance of access to the radial artery in reducing post-procedural AKI highlights the possibility of a safer alternative. Evidence-based access site selection is becoming more crucial in the age of patient-centered healthcare to improve procedural outcomes.
该研究着眼于当代医学中桡动脉的使用,以降低急性肾损伤(AKI)的发生率。为了提高以患者为中心的手术安全性,本文评估了桡骨入路与股骨入路对比的证据。目的:确定介入手术中是否有桡动脉通路和AKI的发生率,重点评估桡动脉通路在降低AKI风险方面的可能优势。方法:对132例患者进行回顾性检查,并按入路位置(桡动脉相对于其他部位)进行分类。从2022年9月开始到2023年3月结束,研究时间为6个月。AKI发生率、手术细节和人口学数据进行比较。采用多变量logistic回归评估径向通路对AKI风险的独立影响。结果:桡动脉组AKI发生率(13.6%)明显低于对照组(27.3%)。多变量分析证实了独立关联。结论:桡动脉通路与减少术后AKI的可能相关性强调了一种更安全的替代方案的可能性。在以患者为中心的医疗保健时代,循证访问地点的选择变得越来越重要,以改善手术结果。
{"title":"Association of Access to the Radial Artery with Reduced Incidence of Acute Kidney Injury","authors":"Sanjay Gandhi, Haris Khan, Umer Bin Tariq, Gulfan Ullah, Akmal Zubair","doi":"10.54393/pjhs.v4i10.1100","DOIUrl":"https://doi.org/10.54393/pjhs.v4i10.1100","url":null,"abstract":"The research looks at access to the radial artery in contemporary medicine to lower the occurrence of acute kidney injury (AKI). In an effort to increase patient-centered procedural safety, it evaluates evidence contrasting radial versus femoral access. Objective: To determine if access to the radial artery and the prevalence of AKI during interventional procedures, with an emphasis on evaluating the possible advantages of radial access in lowering the risk of AKI. Methods: An examination of 132 instances classified by access location (radial artery as opposed to other sites) was done retrospectively. Beginning in September 2022 and ending in March 2023, the study's length was six months. AKI incidence, procedure specifics, and demographic data were compared. The independent influence of radial access on the risk of AKI was evaluated using multivariate logistic regression. Results: The radial artery group (13.6%) exhibited a significantly lower AKI incidence than the comparator group (27.3%). Multivariate analysis confirmed the independent association. Conclusions: The possible relevance of access to the radial artery in reducing post-procedural AKI highlights the possibility of a safer alternative. Evidence-based access site selection is becoming more crucial in the age of patient-centered healthcare to improve procedural outcomes.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concomitant CABG vs. CABG Alone - A Comparative Analysis of Early Outcomes 合并冠脉搭桥与单独冠脉搭桥——早期结果的比较分析
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.54393/pjhs.v4i09.986
None Muhammad Wasim Sajjad, None Sarmad Saeed khattak, None Saif Ullah, None Azam Jan, None Muhammad Salman Farsi, None Rashid Qayyum, None Marghalara Bangash
Concomitant CABG is performed in combination with other cardiac procedures (VHD, CHD) while CABG is performed exclusively for CAD. Objective: To compare the mortality and perioperative outcomes between CABG and concomitant CABG for proper quoting of risk & optimizing the treatment decision for improved patient outcomes. Methods: The observational study on retrospective data was conducted at Rehman Medical Institute from December 2020 to December 2022. A total of 169 patients were included, with 89 in the CABG and 80 in the concomitant CABG group. Ethical approval was granted and inclusion criteria were met. Data were analyzed using SPSS 25. Results: A total of 169 patients were included with a mean age of 57.72±10.65 & the majority of the male population (77.5%). Most of the patients had NYHA III (56.1%) & CCS III (43.9%) class symptoms. Hypertension was our most common co-morbidity (58.0%), followed by dyslipidemia (52.3%) & DM (47.3%). Concomitant CABG has the worst parameters in terms of intraoperative characteristics such as a statistically significant higher rate of intraoperative transfusion (p <0.001), prolonged perfusion (p <0.001) & cross-clamp time (p<0.001). Similarly, concomitant CABG patients have the worst postoperative outcomes with a significantly higher incidence of mortality (p <0.001), post-operative transfusion requirement (p 0.008), increased duration of mechanical ventilation hours (p 0.005), extended hours of ICU stay (p 0.02) & higher rates of re-intubation (p 0.03). Conclusions: Concomitant CABG is no doubt a high-risk procedure as signified by its worst outcomes.
合并冠脉搭桥与其他心脏手术(VHD, CHD)联合进行,而冠脉搭桥仅用于CAD。目的:比较冠状动脉搭桥与合并冠状动脉搭桥的死亡率和围手术期预后,为正确评价风险提供参考。优化治疗决策以改善患者预后。方法:于2020年12月至2022年12月在Rehman医学研究所进行回顾性观察研究。共纳入169例患者,其中冠脉搭桥组89例,合并冠脉搭桥组80例。经伦理批准并符合纳入标准。数据采用SPSS 25进行分析。结果:共纳入169例患者,平均年龄57.72±10.65;男性人口占多数(77.5%)。大多数患者为NYHA III型(56.1%);CCS III(43.9%)级症状。高血压是我们最常见的合并症(58.0%),其次是血脂异常(52.3%);DM(47.3%)。在术中特征方面,合并冠脉搭桥具有最差的参数,如术中输血率(p <0.001)、灌注时间延长(p <0.001);交叉夹紧时间(p<0.001)。同样,合并CABG患者的术后预后最差,死亡率(p <0.001)、术后输血需求(p <0.001)、机械通气时间增加(p < 0.05)、ICU住院时间延长(p <0.001);再插管率较高(p = 0.03)。结论:合并冠脉搭桥无疑是一种高风险手术,其最坏的结果表明。
{"title":"Concomitant CABG vs. CABG Alone - A Comparative Analysis of Early Outcomes","authors":"None Muhammad Wasim Sajjad, None Sarmad Saeed khattak, None Saif Ullah, None Azam Jan, None Muhammad Salman Farsi, None Rashid Qayyum, None Marghalara Bangash","doi":"10.54393/pjhs.v4i09.986","DOIUrl":"https://doi.org/10.54393/pjhs.v4i09.986","url":null,"abstract":"Concomitant CABG is performed in combination with other cardiac procedures (VHD, CHD) while CABG is performed exclusively for CAD. Objective: To compare the mortality and perioperative outcomes between CABG and concomitant CABG for proper quoting of risk &amp; optimizing the treatment decision for improved patient outcomes. Methods: The observational study on retrospective data was conducted at Rehman Medical Institute from December 2020 to December 2022. A total of 169 patients were included, with 89 in the CABG and 80 in the concomitant CABG group. Ethical approval was granted and inclusion criteria were met. Data were analyzed using SPSS 25. Results: A total of 169 patients were included with a mean age of 57.72±10.65 &amp; the majority of the male population (77.5%). Most of the patients had NYHA III (56.1%) &amp; CCS III (43.9%) class symptoms. Hypertension was our most common co-morbidity (58.0%), followed by dyslipidemia (52.3%) &amp; DM (47.3%). Concomitant CABG has the worst parameters in terms of intraoperative characteristics such as a statistically significant higher rate of intraoperative transfusion (p <0.001), prolonged perfusion (p <0.001) &amp; cross-clamp time (p<0.001). Similarly, concomitant CABG patients have the worst postoperative outcomes with a significantly higher incidence of mortality (p <0.001), post-operative transfusion requirement (p 0.008), increased duration of mechanical ventilation hours (p 0.005), extended hours of ICU stay (p 0.02) &amp; higher rates of re-intubation (p 0.03). Conclusions: Concomitant CABG is no doubt a high-risk procedure as signified by its worst outcomes.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135038363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Intravenous Tranexamic Acid in Prevention of Seroma Formation after Umbilical and Para Umbilical Hernioplasty 静脉注射氨甲环酸在预防脐疝和脐旁疝成形术后血清肿形成中的作用
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.54393/pjhs.v4i09.910
Imran Jariullah, Muhammad Ghayasuddin, Syeda Alisha Ali Zaidi, Muhammad Ali, Wahb Noor Zia, Ramsha Waseem, Zaffar Ali, Khadijah Abid
Umbilical and paraumbilical hernias are common conditions affecting a significant portion of the global population, with surgical intervention being a common treatment modality. Seroma formation is a common complication after hernioplasty. Tranexamic acid (TXA) has emerged as a promising prophylactic agent for seroma prevention, as it inhibits fibrin breakdown, reducing blood loss and blood transfusions. Objective: To evaluate the role of intravenous tranexamic acid in the prevention of seroma formation after umbilical and paraumbilical hernioplasty. Methods: It was a cohort study conducted at the department of surgery, Kulsoom Bai Valika Hospital, Karachi, Pakistan from Oct 2022 to Apr 2022. Patients aged 18 years or above who underwent umbilical and paraumbilical hernioplasty of either gender were involved in the study. The individuals were then categorized into two groups: the exposed group, consisting of patients who received intravenous tranexamic acid (IVTXA), and the unexposed group, comprising of patients who did not receive IVTXA. Both groups were monitored for a duration of three months to assess the incidence of seroma formation. Results: Out of 30 patients in each group, 4 patients (13.3%) in the IVTXA group developed seroma, while 26 patients (86.7%) in the Without TXA group developed seroma. This difference was statistically significant with p-value=0.0021. The risk of seroma formation is 0.22 times lesser in patients with intravenous tranexamic acid as compared to patients without tranexamic acid (RR=0.22, 95% CI: 0.12-0.91). Conclusions: IVTXA may be effective in preventing seroma formation after umbilical and paraumbilical hernioplasty.
脐疝和脐旁疝是影响全球很大一部分人口的常见疾病,手术干预是一种常见的治疗方式。血清肿形成是疝成形术后常见的并发症。氨甲环酸(TXA)已成为一种很有前途的预防血清肿的药物,因为它可以抑制纤维蛋白分解,减少失血和输血。目的:探讨静脉注射氨甲环酸对脐疝及脐旁疝成形术后血清肿形成的预防作用。方法:采用队列研究方法,于2022年10月至2022年4月在巴基斯坦卡拉奇Kulsoom Bai Valika医院外科进行。年龄在18岁或以上,接受过脐疝和脐旁疝成形术的患者,无论性别,都参与了这项研究。然后将这些个体分为两组:暴露组,由接受静脉注射氨甲环酸(IVTXA)的患者组成;未暴露组,由不接受IVTXA的患者组成。对两组患者进行为期三个月的监测,以评估血清肿形成的发生率。结果:每组30例患者中,IVTXA组有4例(13.3%)发生血肿,而无TXA组有26例(86.7%)发生血肿。差异有统计学意义,p值=0.0021。静脉注射氨甲环酸的患者与不注射氨甲环酸的患者相比,血清形成的风险低0.22倍(RR=0.22, 95% CI: 0.12-0.91)。结论:IVTXA可有效预防脐疝及脐旁疝成形术后血清肿的形成。
{"title":"Role of Intravenous Tranexamic Acid in Prevention of Seroma Formation after Umbilical and Para Umbilical Hernioplasty","authors":"Imran Jariullah, Muhammad Ghayasuddin, Syeda Alisha Ali Zaidi, Muhammad Ali, Wahb Noor Zia, Ramsha Waseem, Zaffar Ali, Khadijah Abid","doi":"10.54393/pjhs.v4i09.910","DOIUrl":"https://doi.org/10.54393/pjhs.v4i09.910","url":null,"abstract":"Umbilical and paraumbilical hernias are common conditions affecting a significant portion of the global population, with surgical intervention being a common treatment modality. Seroma formation is a common complication after hernioplasty. Tranexamic acid (TXA) has emerged as a promising prophylactic agent for seroma prevention, as it inhibits fibrin breakdown, reducing blood loss and blood transfusions. Objective: To evaluate the role of intravenous tranexamic acid in the prevention of seroma formation after umbilical and paraumbilical hernioplasty. Methods: It was a cohort study conducted at the department of surgery, Kulsoom Bai Valika Hospital, Karachi, Pakistan from Oct 2022 to Apr 2022. Patients aged 18 years or above who underwent umbilical and paraumbilical hernioplasty of either gender were involved in the study. The individuals were then categorized into two groups: the exposed group, consisting of patients who received intravenous tranexamic acid (IVTXA), and the unexposed group, comprising of patients who did not receive IVTXA. Both groups were monitored for a duration of three months to assess the incidence of seroma formation. Results: Out of 30 patients in each group, 4 patients (13.3%) in the IVTXA group developed seroma, while 26 patients (86.7%) in the Without TXA group developed seroma. This difference was statistically significant with p-value=0.0021. The risk of seroma formation is 0.22 times lesser in patients with intravenous tranexamic acid as compared to patients without tranexamic acid (RR=0.22, 95% CI: 0.12-0.91). Conclusions: IVTXA may be effective in preventing seroma formation after umbilical and paraumbilical hernioplasty.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Radiation Dose and Contrast Dye Volume Comparison in Coronary Angiography Via Femoral and Radial Routes 经股、径路冠状动脉造影放射剂量和造影剂体积的比较
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.54393/pjhs.v4i09.1109
Hidayat Ullah, Muhammad Shafique Arshad, Zabih Ullah, Abdul Rehman, Muhammad Khalil, Nouman Khan
Coronary angiography is a common procedure used to identify coronary artery disease. Whether femoral or radial vascular access is employed may impact radiation dosage and contrast dye utilization. This study examined radiation exposure and contrast dye volume in femoral and radial approach in patients undergoing coronary angiography. Objective: To assess and compare the radiation dosage and contrast dye volume between patients having coronary angiography through the femoral and radial routes. Methods: A prospective study included 408 consecutive coronary angiography patients from April 10 to August 31, 2023. The remaining 206 patients were treated radially, while 202 were treated femorally. We examined radiation exposure, dose area product (DAP), and contrast dye volume among groups. Results: Radial and femoral groups had similar mean ages (64.4±12.1 vs. 64.8±11.6, p=0.86). The radial group had 60.67% men versus 71.3% in femoral group. Radial and femoral catheterization radiation doses were 1.199 Gy (0.677-2.001) and 1.218 Gy (0.696-2.207), respectively, with a p-value of 0.88 showing no group radiation exposure difference. The group analysis found no hemorrhagic consequences from radial or femoral catheterization, coronarography, or angioplasty. Conclusions: The study participants noticed non-significant differences in contrast dye volume and radiation dose between femoral and radial coronary angiography.
冠状动脉造影是一种常用的诊断冠状动脉疾病的方法。采用股骨或桡动脉血管通路可能影响辐射剂量和造影剂的使用。本研究检查了接受冠状动脉造影的患者股骨和桡动脉入路的辐射暴露和造影剂体积。目的:评价和比较经股路和经桡动脉行冠状动脉造影患者的放射剂量和造影剂体积。方法:前瞻性研究纳入2023年4月10日至8月31日连续408例冠状动脉造影患者。其余206例患者采用桡骨治疗,202例采用股骨治疗。我们检查了各组间的辐射暴露、剂量面积积(DAP)和造影剂体积。结果:桡骨组和股骨组平均年龄相近(64.4±12.1∶64.8±11.6,p=0.86)。桡骨组为60.67%,股骨组为71.3%。桡骨和股骨置管放射剂量分别为1.199 Gy(0.677-2.001)和1.218 Gy (0.696-2.207), p值为0.88,各组放射暴露无差异。组内分析未发现桡动脉或股动脉导管、冠状造影或血管成形术的出血后果。结论:研究参与者注意到股动脉和桡动脉冠状动脉造影在造影剂体积和辐射剂量上没有显著差异。
{"title":"Comparison of Radiation Dose and Contrast Dye Volume Comparison in Coronary Angiography Via Femoral and Radial Routes","authors":"Hidayat Ullah, Muhammad Shafique Arshad, Zabih Ullah, Abdul Rehman, Muhammad Khalil, Nouman Khan","doi":"10.54393/pjhs.v4i09.1109","DOIUrl":"https://doi.org/10.54393/pjhs.v4i09.1109","url":null,"abstract":"Coronary angiography is a common procedure used to identify coronary artery disease. Whether femoral or radial vascular access is employed may impact radiation dosage and contrast dye utilization. This study examined radiation exposure and contrast dye volume in femoral and radial approach in patients undergoing coronary angiography. Objective: To assess and compare the radiation dosage and contrast dye volume between patients having coronary angiography through the femoral and radial routes. Methods: A prospective study included 408 consecutive coronary angiography patients from April 10 to August 31, 2023. The remaining 206 patients were treated radially, while 202 were treated femorally. We examined radiation exposure, dose area product (DAP), and contrast dye volume among groups. Results: Radial and femoral groups had similar mean ages (64.4±12.1 vs. 64.8±11.6, p=0.86). The radial group had 60.67% men versus 71.3% in femoral group. Radial and femoral catheterization radiation doses were 1.199 Gy (0.677-2.001) and 1.218 Gy (0.696-2.207), respectively, with a p-value of 0.88 showing no group radiation exposure difference. The group analysis found no hemorrhagic consequences from radial or femoral catheterization, coronarography, or angioplasty. Conclusions: The study participants noticed non-significant differences in contrast dye volume and radiation dose between femoral and radial coronary angiography.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135131351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency of Low Birth Weight in Patients with Gestational Hypertension 妊娠期高血压患者低出生体重的发生率
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.54393/pjhs.v4i09.1019
Anum Farhan, Sidra Tariq, Maria Tasneem, Daniya Khan, Sanam Chachar, Hamna Sabih Baqai, Kamran Fazal
Preterm birth and low birth weight are just two negative fetal outcomes that are linked to PIH. The WHO divides infants into three categories based on birth weight and gestational age: Small for gestational age, Appropriate for gestational age, and Large for gestational age. LBW babies are those who weigh less than 2.5kg within 24 hours of birth, according to these standards. Objectives: To determine the frequency of low birth weight in patients with gestational hypertension. Methods: This Descriptive study was done in department of Obstetrics and Gynecology unit III, Civil Hospital Karachi from 16th February 2019 to 15th August 2019. We enrolled 89women diagnosed with gestational hypertension meeting the criteria. Informed consent was taken. Results: Age range in this study was from 20 to 45 years with majority of the patients 52 (58.43%) were between 18 to 30 years of age. Mean gestational age was 39.51±2.7 weeks. Frequency of low birth weight in patients with gestational hypertension was found in 27 (30.34%) patients. Conclusions: This study concluded that frequency of low birth weight in patients with gestational hypertension is very high.
早产和低出生体重只是与妊高征相关的两种负面胎儿结果。世卫组织根据出生体重和胎龄将婴儿分为三类:胎龄小、胎龄适宜和胎龄大。根据这些标准,LBW婴儿是指出生24小时内体重低于2.5公斤的婴儿。目的:了解妊娠期高血压患者低出生体重的发生率。方法:本描述性研究于2019年2月16日至2019年8月15日在卡拉奇民用医院妇产科第三单元进行。我们招募了89名符合标准的诊断为妊娠期高血压的妇女。采取知情同意。结果:本组患者年龄范围为20 ~ 45岁,其中18 ~ 30岁占52例(58.43%)的多数。平均胎龄39.51±2.7周。27例(30.34%)妊娠期高血压患者出现低出生体重。结论:妊娠期高血压患者低出生体重发生率高。
{"title":"Frequency of Low Birth Weight in Patients with Gestational Hypertension","authors":"Anum Farhan, Sidra Tariq, Maria Tasneem, Daniya Khan, Sanam Chachar, Hamna Sabih Baqai, Kamran Fazal","doi":"10.54393/pjhs.v4i09.1019","DOIUrl":"https://doi.org/10.54393/pjhs.v4i09.1019","url":null,"abstract":"Preterm birth and low birth weight are just two negative fetal outcomes that are linked to PIH. The WHO divides infants into three categories based on birth weight and gestational age: Small for gestational age, Appropriate for gestational age, and Large for gestational age. LBW babies are those who weigh less than 2.5kg within 24 hours of birth, according to these standards. Objectives: To determine the frequency of low birth weight in patients with gestational hypertension. Methods: This Descriptive study was done in department of Obstetrics and Gynecology unit III, Civil Hospital Karachi from 16th February 2019 to 15th August 2019. We enrolled 89women diagnosed with gestational hypertension meeting the criteria. Informed consent was taken. Results: Age range in this study was from 20 to 45 years with majority of the patients 52 (58.43%) were between 18 to 30 years of age. Mean gestational age was 39.51±2.7 weeks. Frequency of low birth weight in patients with gestational hypertension was found in 27 (30.34%) patients. Conclusions: This study concluded that frequency of low birth weight in patients with gestational hypertension is very high.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135037874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quasi Experimental Study to Ascertain Link of PPI to Bone Profile in Healthy Individuals 确定PPI与健康个体骨骼结构关系的准实验研究
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.54393/pjhs.v4i09.1039
Yasra Memon, Imran Ali Shaikh, Imran Karim
Proton pump inhibitor (PPI) is only acid blocking agent used for treating the disease known as gastroesophageal reflux (non-erosive), erosive esophagitis disease, dyspepsia disease and the peptic ulcer disease because of its efficacy and potency. However, overuse of it is examined an immediate result of absence of determination of need for steady treatment in many outdoor subjects Objective: To evaluate impact of proton pump inhibitor (PPI) on bone biochemistry in young individuals of Hyderabad. Methods: The study contained 227 young individuals of age 20-45 years, it was conducted in Liaquat University Hospital, Hyderabad City and Medicine OPD’s of Jamshoro. The research study is undertaken using Quasi experimental study. The study duration is 6 months starting from 15th March 2020 to 15th September 2020 and sampling technique is non – probability convenience. SPSS 21 software is used to analyze the data. The post stratification chi – square test is performed at the interval of 95% confidence, besides it the P-value is observed ≤ 0.05. Results: There is no effect on serum calcium and vitamin D levels with use of proton pump inhibitor PPI. P-value was observed 0.7 for the serum calcium and the p- value for Serum Vitamin D was 0.1. Conclusions: Hence, the study showed that proton pump inhibitor PPI use for less than 6 months have no effect on bone biochemistry.
质子泵抑制剂(PPI)是唯一的酸阻断剂,用于治疗疾病称为胃食管反流(非糜烂),糜烂性食管炎疾病,消化不良疾病和消化性溃疡疾病,因为它的疗效和效力。然而,在许多户外受试者中,由于缺乏对稳定治疗需求的确定,过度使用PPI被认为是直接的结果。目的:评估质子泵抑制剂(PPI)对海德拉巴年轻人骨生化的影响。方法:在海得拉巴市利亚奎特大学医院和贾姆肖洛医学门诊进行了227例20-45岁的年轻人的研究。本研究采用准实验研究方法进行。研究时间为6个月,从2020年3月15日至2020年9月15日,抽样技术是非概率方便的。采用SPSS 21软件对数据进行分析。分层后卡方检验在95%置信区间内进行,p值≤0.05。结果:质子泵抑制剂PPI对血清钙、维生素D水平无影响。血清钙p值为0.7,血清维生素D p值为0.1。结论:因此,本研究表明质子泵抑制剂PPI使用少于6个月对骨生化没有影响。
{"title":"Quasi Experimental Study to Ascertain Link of PPI to Bone Profile in Healthy Individuals","authors":"Yasra Memon, Imran Ali Shaikh, Imran Karim","doi":"10.54393/pjhs.v4i09.1039","DOIUrl":"https://doi.org/10.54393/pjhs.v4i09.1039","url":null,"abstract":"Proton pump inhibitor (PPI) is only acid blocking agent used for treating the disease known as gastroesophageal reflux (non-erosive), erosive esophagitis disease, dyspepsia disease and the peptic ulcer disease because of its efficacy and potency. However, overuse of it is examined an immediate result of absence of determination of need for steady treatment in many outdoor subjects Objective: To evaluate impact of proton pump inhibitor (PPI) on bone biochemistry in young individuals of Hyderabad. Methods: The study contained 227 young individuals of age 20-45 years, it was conducted in Liaquat University Hospital, Hyderabad City and Medicine OPD’s of Jamshoro. The research study is undertaken using Quasi experimental study. The study duration is 6 months starting from 15th March 2020 to 15th September 2020 and sampling technique is non – probability convenience. SPSS 21 software is used to analyze the data. The post stratification chi – square test is performed at the interval of 95% confidence, besides it the P-value is observed ≤ 0.05. Results: There is no effect on serum calcium and vitamin D levels with use of proton pump inhibitor PPI. P-value was observed 0.7 for the serum calcium and the p- value for Serum Vitamin D was 0.1. Conclusions: Hence, the study showed that proton pump inhibitor PPI use for less than 6 months have no effect on bone biochemistry.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135038905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Abdominal Ultrasound to Detect Benign Prostatic Hyperplasia with Significant Factor of Age 腹部超声对年龄因素显著的良性前列腺增生的诊断作用
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.54393/pjhs.v4i09.978
Muhammad Ahmad Raza, Amna Sana, Laamia Altuf, Hajra Sultan, Rabia Parveen
Mostly in men, benign prostatic hyperplasia is serious issue. The volume of BPH increasing withurinary retention and is mostly determined by transabdominal sonography.Prostatic volumeinteractednegatively withhigh density lipoprotein cholesterol. Mostly occurrenceof BPHinmen with age of 45 to 60 years. BPH have lower urinary tract symptoms. About 20 recentpublicationssuitableforliteraturereviewwereretrievedfromdifferentdatabaseslikePubMed, sci.hub, and google scholar. The search on databases & search engines identified 27articles related to topic, among which only 20 articles were as per requirement. Only 20 articleswere usedfor extraction of data related to role of Abdominalultrasound todetectbenignprostatic hyperplasia. The current study looked at the detection of BPH with age. This review hasconclusionsthatultrasoundisamodalityofchoiceforevaluatingthepatientwithBPH,ithelpsin diagnosis as well as prediction of urinary retention and age has a significant factor in BPH.
在男性中,良性前列腺增生是一个严重的问题。前列腺增生体积随着尿潴留而增加,主要通过经腹超声检查确定。前列腺体积与高密度脂蛋白胆固醇呈负相关。主要发生于45至60岁的男性。BPH有下尿路症状。我们从pubmed、sci等不同的数据库中检索了大约20篇适合文献综述的近期出版物。Hub和Google scholar。数据库搜索&搜索引擎识别出27篇与主题相关的文章,其中符合要求的文章只有20篇。仅20篇文章用于提取与腹部超声检测良性前列腺增生相关的数据。目前的研究着眼于BPH随年龄的变化。本综述认为,超声检查对BPH患者的评估、诊断的帮助以及尿潴留和年龄的预测是BPH的重要因素。
{"title":"Role of Abdominal Ultrasound to Detect Benign Prostatic Hyperplasia with Significant Factor of Age","authors":"Muhammad Ahmad Raza, Amna Sana, Laamia Altuf, Hajra Sultan, Rabia Parveen","doi":"10.54393/pjhs.v4i09.978","DOIUrl":"https://doi.org/10.54393/pjhs.v4i09.978","url":null,"abstract":"Mostly in men, benign prostatic hyperplasia is serious issue. The volume of BPH increasing withurinary retention and is mostly determined by transabdominal sonography.Prostatic volumeinteractednegatively withhigh density lipoprotein cholesterol. Mostly occurrenceof BPHinmen with age of 45 to 60 years. BPH have lower urinary tract symptoms. About 20 recentpublicationssuitableforliteraturereviewwereretrievedfromdifferentdatabaseslikePubMed, sci.hub, and google scholar. The search on databases &amp; search engines identified 27articles related to topic, among which only 20 articles were as per requirement. Only 20 articleswere usedfor extraction of data related to role of Abdominalultrasound todetectbenignprostatic hyperplasia. The current study looked at the detection of BPH with age. This review hasconclusionsthatultrasoundisamodalityofchoiceforevaluatingthepatientwithBPH,ithelpsin diagnosis as well as prediction of urinary retention and age has a significant factor in BPH.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135038352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Effect of Magnesium Supplementation in Improving Quality of Life among Elderly Insomniac Participants 补充镁对改善老年失眠症患者生活质量的治疗效果
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.54393/pjhs.v4i09.995
Amna Liaqat, Bahisht Rizwan, Ayesha Amjad, Zunaira Rasool
Insomnia is increasing day by day, according to global prevalence it ranges from10%to40%with trouble falling asleep, remaining asleep, or having non-restorative sleep that is accompanied by daytime impairment or distress. Magnesium seems to play a key role in there gelation of sleep. Objective: To compare the therapeutic effect of magnesium supplementation in improving quality of life among elderly insomniac participants with control and treatment group. Methods: The study design was double blind randomized clinical trial. Purposive sampling technique was used to allocate gender elderly people. Data were collected from Al-Saida Shuhda old age home, Lahore and the participants were divided into two groups, 40 participants in each group. Group 0 (control group) were given regular diet without magnesium supplement for 8 weeks. Group 1 (treatment group were given Magnesium supplements (500mg) for 8 weeks. Data were tabulated and analyzed with the help of SPSS 25.0. Results: The results shown that the magnesium supplementation had highly significant results in improving LSEQ, serum magnesium, serum melatonin, serum cortisol and serum renin level without showing any side effects. Group 0 has shown 0.152 (GTS), 0.088(QOS), 0.168(AFS), 0.195(BFW), 0.292(serum Mg), 0.567(serum melatonin), 0.276(serum cortisol), 0.101(serum renin) whereas group 1 has shown 0.01(GTS), 0.01(QOS), 0.003(AFS) and 0.03(BFW), 0.02(serum Mg), 0.01(serum melatonin), 0.02(serum cortisol), 0.02(serum renin), respectively. Conclusions: It was concluded from the results that magnesium supplementation in elderly people has highly significant effects in improving insomnia and quality of sleep.
失眠症日益增多,根据全球患病率,失眠症发生率在10%至40%之间,伴有入睡困难、保持睡眠状态或伴有白天障碍或痛苦的非恢复性睡眠。镁似乎在睡眠凝胶中起着关键作用。目的:比较补镁对老年失眠症患者生活质量的改善作用与对照组和治疗组的差异。方法:采用双盲随机临床试验。采用目的抽样方法对性别老年人进行分配。数据从拉合尔的Al-Saida Shuhda养老院收集,参与者分为两组,每组40名参与者。0组(对照组)给予正常饮食,不添加镁,持续8周。组1(治疗组)给予镁补充剂(500mg),连续8周。用SPSS 25.0软件对数据进行统计和分析。结果:结果显示,补镁对改善LSEQ、血清镁、血清褪黑素、血清皮质醇和血清肾素水平均有极显著效果,且无副作用。0组分别为0.152 (GTS)、0.088(QOS)、0.168(AFS)、0.195(BFW)、0.292(血清Mg)、0.567(血清褪黑素)、0.276(血清皮质醇)、0.101(血清肾素);1组分别为0.01(GTS)、0.01(QOS)、0.003(AFS)、0.03(BFW)、0.02(血清Mg)、0.01(血清褪黑素)、0.02(血清皮质醇)、0.02(血清肾素)。结论:老年人补充镁对改善失眠和睡眠质量有非常显著的作用。
{"title":"Therapeutic Effect of Magnesium Supplementation in Improving Quality of Life among Elderly Insomniac Participants","authors":"Amna Liaqat, Bahisht Rizwan, Ayesha Amjad, Zunaira Rasool","doi":"10.54393/pjhs.v4i09.995","DOIUrl":"https://doi.org/10.54393/pjhs.v4i09.995","url":null,"abstract":"Insomnia is increasing day by day, according to global prevalence it ranges from10%to40%with trouble falling asleep, remaining asleep, or having non-restorative sleep that is accompanied by daytime impairment or distress. Magnesium seems to play a key role in there gelation of sleep. Objective: To compare the therapeutic effect of magnesium supplementation in improving quality of life among elderly insomniac participants with control and treatment group. Methods: The study design was double blind randomized clinical trial. Purposive sampling technique was used to allocate gender elderly people. Data were collected from Al-Saida Shuhda old age home, Lahore and the participants were divided into two groups, 40 participants in each group. Group 0 (control group) were given regular diet without magnesium supplement for 8 weeks. Group 1 (treatment group were given Magnesium supplements (500mg) for 8 weeks. Data were tabulated and analyzed with the help of SPSS 25.0. Results: The results shown that the magnesium supplementation had highly significant results in improving LSEQ, serum magnesium, serum melatonin, serum cortisol and serum renin level without showing any side effects. Group 0 has shown 0.152 (GTS), 0.088(QOS), 0.168(AFS), 0.195(BFW), 0.292(serum Mg), 0.567(serum melatonin), 0.276(serum cortisol), 0.101(serum renin) whereas group 1 has shown 0.01(GTS), 0.01(QOS), 0.003(AFS) and 0.03(BFW), 0.02(serum Mg), 0.01(serum melatonin), 0.02(serum cortisol), 0.02(serum renin), respectively. Conclusions: It was concluded from the results that magnesium supplementation in elderly people has highly significant effects in improving insomnia and quality of sleep.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135038357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life in Children with Cerebral Palsy 脑性麻痹儿童的生活质量
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.54393/pjhs.v4i09.1042
Sidra Hanif, Arooj Zameer, Hamra Waheed, Faryal Zaidi, Ishaq Ahmed, Maham Choudary
Cerebral palsy refers to a non-progressive brain disorder that affects the development of brain in developing infant and reduces the quality of life. Quality of life (QOL) is assessed using the CPQOL tool. Objectives: To assess the quality of life of children with CP. Methods: A cross-sectional study was conducted at the National Institute of Rehabilitation Medicine, Islamabad during Oct-2022 to Mar-2023. The sample was raised using slovin’s formula and non-probability convenient sampling technique was used. Data were collected using standard CP-QOL tool. All types of CP diagnosed cases both gender, presence of a caregiver and an age range of 4 to 12 years were included. Patients with non-availability of a caregiver and presence of any other illness not associated with CP were excluded. Results: Out of 129 participants, 105 were included on the basis of inclusion and exclusion criteria. The mean ± SD of patients overall score came out to be 46.83 ±9.75. CPQOL score of males were 47.36±9.96 and of female was 46.19±9.56. CPQOL score of age 4-6years was 45.12±10.58, 7-9 years was 47.70±9.15 and 10-12 years was 49.21±8.54 while overall CPQOL score of children with diplegic CP was 48.38±9.11, hemiplegic CP was 48.66±7.74, quadriplegic CP was 37.92±11.16. Conclusions: study showed that among both genders, females had poor QoL than males. This study also concluded that quadriplegic children had poor QoL than any other types of cerebral palsy. The overall status of QoL of children having Cerebral Palsy was low.
脑瘫是指影响发育中的婴儿大脑发育,降低生活质量的一种非进行性脑部疾病。使用CPQOL工具评估生活质量(QOL)。目的:评估CP患儿的生活质量。方法:横断面研究于2022年10月至2023年3月在伊斯兰堡国家康复医学研究所进行。采用slovin公式提出样本,并采用非概率方便抽样技术。采用标准CP-QOL工具收集数据。所有类型的CP诊断病例,包括性别,是否有护理者,年龄范围为4至12岁。没有护理人员和存在任何其他与CP无关的疾病的患者被排除在外。结果:在129名受试者中,105人根据纳入和排除标准被纳入。患者总得分的平均值±SD为46.83±9.75。男性CPQOL评分为47.36±9.96,女性为46.19±9.56。4 ~ 6岁CPQOL评分为45.12±10.58,7 ~ 9岁CPQOL评分为47.70±9.15,10 ~ 12岁CPQOL评分为49.21±8.54,而双瘫CP总分为48.38±9.11,偏瘫CP总分为48.66±7.74,四肢瘫CP总分为37.92±11.16。结论:研究表明,无论男女,女性的生活质量都比男性差。这项研究还得出结论,四肢瘫痪儿童的生活质量比任何其他类型的脑瘫儿童都差。脑瘫患儿总体生活质量较低。
{"title":"Quality of life in Children with Cerebral Palsy","authors":"Sidra Hanif, Arooj Zameer, Hamra Waheed, Faryal Zaidi, Ishaq Ahmed, Maham Choudary","doi":"10.54393/pjhs.v4i09.1042","DOIUrl":"https://doi.org/10.54393/pjhs.v4i09.1042","url":null,"abstract":"Cerebral palsy refers to a non-progressive brain disorder that affects the development of brain in developing infant and reduces the quality of life. Quality of life (QOL) is assessed using the CPQOL tool. Objectives: To assess the quality of life of children with CP. Methods: A cross-sectional study was conducted at the National Institute of Rehabilitation Medicine, Islamabad during Oct-2022 to Mar-2023. The sample was raised using slovin’s formula and non-probability convenient sampling technique was used. Data were collected using standard CP-QOL tool. All types of CP diagnosed cases both gender, presence of a caregiver and an age range of 4 to 12 years were included. Patients with non-availability of a caregiver and presence of any other illness not associated with CP were excluded. Results: Out of 129 participants, 105 were included on the basis of inclusion and exclusion criteria. The mean ± SD of patients overall score came out to be 46.83 ±9.75. CPQOL score of males were 47.36±9.96 and of female was 46.19±9.56. CPQOL score of age 4-6years was 45.12±10.58, 7-9 years was 47.70±9.15 and 10-12 years was 49.21±8.54 while overall CPQOL score of children with diplegic CP was 48.38±9.11, hemiplegic CP was 48.66±7.74, quadriplegic CP was 37.92±11.16. Conclusions: study showed that among both genders, females had poor QoL than males. This study also concluded that quadriplegic children had poor QoL than any other types of cerebral palsy. The overall status of QoL of children having Cerebral Palsy was low.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135037873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Factor V Leiden Mutation in Healthy Females of Sindh, Pakistan and Comparison of Three Detection Methods in Resource-Limited Settings 巴基斯坦信德省健康女性中Leiden因子V突变的流行及三种检测方法在资源有限环境下的比较
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.54393/pjhs.v4i09.1007
Feriha Fatima Khidri, Hina Riaz, Yar Muhammad Waryah, Roohi Nigar, Ali Muhammad Waryah
Factor V Leiden (FVL) mutation is related to venous thromboembolism and pregnancy complications. It is highly prevalent among Caucasians; however, few studies have been conducted on the Asian population. Objective: To find the prevalence, genotype, and allelic frequency of FVL mutation in females of Sindh, Pakistan, and to develop a valid and economical method for the detection of FVL mutation in resource-limited settings. Methods: Hundred (n=100), unrelated healthy females of Sindh, Pakistan, were recruited. FVL was detected using three methods, i.e., tetra primer amplification refractory mutation system (ARMS)-polymerase chain reaction (PCR), PCR-restriction fragment length polymorphism (PCR-RFLP), and PCR-sequencing. Prevalence, genotype, and allele frequencies were calculated. We compared the three mutation detection methods to find a suitable protocol for FVL detection in developing countries. Results: The prevalence of FVL mutation was 3% in healthy females of Sindh, Pakistan. No homozygous FVL mutation was found. The results from tetra primer ARMS-PCR, PCR-RFLP, and PCR-sequencing were 100% concordant. Tetra primer ARMS-PCR was a valid, reliable, faster, economical genotyping and screening method. Conclusions: In conclusion, FVL mutation was found in our population, and further studies should be conducted to find its role in thromboembolic and obstetrical complications. In addition, we have suggested tetra primer ARMS-PCR as an appropriate method for FVL detection in resource-limited settings.
因子V莱顿(FVL)突变与静脉血栓栓塞和妊娠并发症有关。它在白种人中非常普遍;然而,很少有针对亚洲人口的研究。目的:了解巴基斯坦信德省女性FVL突变的流行情况、基因型和等位基因频率,为资源有限地区FVL突变的检测提供一种有效、经济的方法。方法:选取巴基斯坦信德省无亲属关系的健康女性100例(n=100)。FVL检测采用四引物扩增难解突变系统(ARMS)-聚合酶链反应(PCR)、PCR-限制性片段长度多态性(PCR- rflp)和PCR-测序三种方法。计算患病率、基因型和等位基因频率。我们比较了三种突变检测方法,以寻找适合发展中国家的FVL检测方案。结果:巴基斯坦信德省健康女性FVL突变患病率为3%。未发现纯合子FVL突变。四引物ARMS-PCR、PCR-RFLP和pcr -测序结果一致性为100%。四联引物ARMS-PCR是一种有效、可靠、快速、经济的基因分型和筛选方法。结论:在我们的人群中发现了FVL突变,应进一步研究其在血栓栓塞和产科并发症中的作用。此外,我们建议在资源有限的情况下,四引物ARMS-PCR作为FVL检测的合适方法。
{"title":"Prevalence of Factor V Leiden Mutation in Healthy Females of Sindh, Pakistan and Comparison of Three Detection Methods in Resource-Limited Settings","authors":"Feriha Fatima Khidri, Hina Riaz, Yar Muhammad Waryah, Roohi Nigar, Ali Muhammad Waryah","doi":"10.54393/pjhs.v4i09.1007","DOIUrl":"https://doi.org/10.54393/pjhs.v4i09.1007","url":null,"abstract":"Factor V Leiden (FVL) mutation is related to venous thromboembolism and pregnancy complications. It is highly prevalent among Caucasians; however, few studies have been conducted on the Asian population. Objective: To find the prevalence, genotype, and allelic frequency of FVL mutation in females of Sindh, Pakistan, and to develop a valid and economical method for the detection of FVL mutation in resource-limited settings. Methods: Hundred (n=100), unrelated healthy females of Sindh, Pakistan, were recruited. FVL was detected using three methods, i.e., tetra primer amplification refractory mutation system (ARMS)-polymerase chain reaction (PCR), PCR-restriction fragment length polymorphism (PCR-RFLP), and PCR-sequencing. Prevalence, genotype, and allele frequencies were calculated. We compared the three mutation detection methods to find a suitable protocol for FVL detection in developing countries. Results: The prevalence of FVL mutation was 3% in healthy females of Sindh, Pakistan. No homozygous FVL mutation was found. The results from tetra primer ARMS-PCR, PCR-RFLP, and PCR-sequencing were 100% concordant. Tetra primer ARMS-PCR was a valid, reliable, faster, economical genotyping and screening method. Conclusions: In conclusion, FVL mutation was found in our population, and further studies should be conducted to find its role in thromboembolic and obstetrical complications. In addition, we have suggested tetra primer ARMS-PCR as an appropriate method for FVL detection in resource-limited settings.","PeriodicalId":45690,"journal":{"name":"Pakistan Journal of Medical & Health Sciences","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135038356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pakistan Journal of Medical & Health Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1